Catamenial Epilepsy

Epilepsy in Women

Volumn , Issue , 2013, Pages 41-52

  Taubøll, Erik ^a   Røste, Line S ^a   Svalheim, Sigrid ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Catamenial epilepsy; Estrogens; Hormonal treatment; Hormones; Progesterone

Indexed keywords

EID: 84886501217     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118531037.ch4     Document Type: Chapter

References (38)

1. Taubøll E, Lundervold A, Gjerstad L. Temporal distribution of seizures in epilepsy. Epilepsy Res 1991; 8: 153-165.
2. Almqvist R. The rhythm of epileptic attacks and its relationship to the menstrual cycle. Acta Psychiatr Neurol Scand Suppl 1955; 105: 1-116.
3. Temkin O. The Falling Sickness. Baltimore: The Johns Hopkins Press, 1945.
4. Gowers WR. Epilepsy and Other Chronic Convulsive Diseases. Their Causes, Symptoms, and Treatment. New York: William Wood, 1885.
5. Laidlaw J. Catamenial epilepsy. Lancet 1956; 271: 1235-1237.
6. Binnie CD, Aarts JHP, Houtkooper MA et al. Temporal characteristics of seizures and epileptiform discharges. Electroencephalogr Clin Neurophysiol 1984; 58: 498-505.
7. Milton JG, Gotman J, Remillard GM, Andermann F. Timing of seizure recurrence in adult epileptic patients: a statistical analysis. Epilepsia 1987; 28: 471-478.
8. Newmark ME. Catamenial epilepsy: a neurological myth persisting for more than 100 years. Epilepsia 1989; 30: 704.
9. Duncan S, Read CL, Brodie MJ. How common is catamenial epilepsy? Epilepsia 1993; 34: 827-831.
10. Herzog AG, Klein P, Ransil BJ. Three patterns of catamenial epilepsy. Epilepsia 1997; 28: 1082-1088.
11. Herzog AG. Catamenial epilepsy: definition, prevalence, pathophysiology and treatment. Seizure 2008; 17: 151-159.
12. Herzog AG, Harden CL, Liporace J et al. Frequency of catamenial seizure exacerbation in women with localization-related epilepsy. Ann Neurol 2004; 56: 431-434.
13. El-Khayat HA, Soliman NA, Tomoum HY, Omran MA, El-Wakad AS, Shatla RH. Reproductive hormonal changes and catamenial pattern in adolescent females with epilepsy. Epilepsia 2008; 49: 1619-1626.
14. Reddy DS. The role of neurosteroids in the pathophysiology and treatment of catamenial epilepsy. Epilepsy Res 2009; 85: 1-30.
15. Bäckström T. Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle. Acta Neurol Scand 1976; 54: 321-347.
16. Herzog AG, Fowler KM, Sperling MR et al. Variation of seizure frequency with ovulatory status of menstrual cycles. Epilepsia 2011; 52: 1843-1848.
17. Herzog AG, Blum AS, Farina EL et al. Valproate and lamotrigine level variation with menstrual cycle phase and oral contraceptive use. Neurology 2009; 72: 911-914.
18. Gilad R, Sadeh M, Rapoport A, Dabby R, Lampl Y. Lamotrigine and catamenial epilepsy. Seizure 2008; 17: 531-534.
19. Logothetis J, Harner, Morrell F, Torres F. The role of estrogens in catamenial exacerbation of epilepsy. Neurology 1959; 9: 352-360.
20. Woolley CS, McEwen BS. Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptor-dependent mechanism. J Neurosci 1994; 14: 7680-7687.
21. Bäckström T, Zetterlund B, Blom S, Romano M. Effects of intravenous progesterone infusions on the epileptic discharge frequency in women with partial epilepsy. Acta Neurol Scand 1984; 69: 240-248.
22. Majewska MD, Harrison NL, Schwartz RD, Barker JL, Paul SM. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 1986; 232: 1004-1007.
23. Taubøll E, Lindström S. The effect of progesterone and its metabolite 5α-pregnan-3α-ol-20-one on focal epileptic seizures in the cat's visual cortex in vivo. Epilepsy Res 1993; 14: 17-30.
24. Maguire JL, Stell BM, Rafizadeh M, Mody I. Ovarian cycle-linked changes in GABA(A) receptors mediating tonic inhibition alter seizure susceptibility and anxiety. Nat Neurosci 2005; 8: 797-804.
25. Reddy DS, Rogawski MA. Neurosteroid replacement therapy for catamenial epilepsy. Neurotherapeutics 2009; 6: 392-401.
26. Stevens SJ, Harden CL. Hormonal therapy for epilepsy. Curr Neurol Neurosci Rep 2011; 11: 435-442.
27. Herzog AG. Intermittent progesterone therapy and frequency of complex partial seizures in women with menstrual disorders. Neurology 1986; 36: 1607-1610.
28. Herzog AG. Progesterone therapy in complex partial and secondary generalized seizures. Neurology 1995; 45: 1660-1662.
29. Herzog AG. Progesterone therapy in women with epilepsy: a 3-year follow-up. Neurology 1999; 52: 1917-1918.
30. Herzog AG, Fowler KM, Smithson SD et al. Progesterone vs placebo therapy for women with epilepsy: a randomized clinical trial. Neurology 2012; 78: 1959-1966.
31. Herzog AG, Frye CA. Seizure exacerbation associated with inhibition of progesterone metabolism. Ann Neurol 2003; 53: 390-391.
32. Zimmerman AW, Holder DT, Reiter EO, Dekaban AS. Medroxyprogesterone acetate in the treatment of seizures associated with menstruation. J Pediatr 1973; 83: 959-963.
33. Mattson RH, Cramer JA, Caldwell BV, Siconolfi BC. Treatment of seizures with medroxyprogesterone acetate: preliminary report. Neurology 1984; 34: 1255-1258.
34. Haider Y, Barnett DB. Catamenial epilepsy and goserelin. Lancet 1991; 338: 1530.
35. Bauer J, Wildt L, Flügel D, Stefan H. The effect of a synthetic GnRH analogue on catamenial epilepsy: a study in ten patients. J Neurol 1992; 239: 284-286.
36. Herzog AG. Clomiphene therapy in epileptic women with menstrual disorders. Neurology 1988; 38: 432-434.
37. Reddy DS, Woodward R. Ganaxolone: a prospective overview. Drugs Future 2004; 29: 227-242.
38. Feely M, Gibson J. Intermittent clobazam for catamenial epilepsy: tolerance avoided. J Neurol Neurosurg Psychiatry 1984; 47: 1279-1282.